# Clinical Trial of the Efficacy and Safety of Raphamin in the Treatment of Acute Bronchitis in Adult Patients

> **NCT07650227** · PHASE3 · RECRUITING · sponsor: **Materia Medica Holding** · enrollment: 308 (estimated)

## Conditions studied

- Bronchitis
- Acute Bronchitis

## Interventions

- **DRUG:** Raphamin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07650227
- **Lead sponsor:** Materia Medica Holding
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-09
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 308 (ESTIMATED)
- **Last updated:** 2026-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07650227

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07650227, "Clinical Trial of the Efficacy and Safety of Raphamin in the Treatment of Acute Bronchitis in Adult Patients". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07650227. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*